hotspot -WSS

hotspot

author：Wikipedia 2025-09-03 03:25:45 - browse：99345

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

focus

explore

WSS

Brazil's Jair Bolsonaro is barred from running for office until 2030

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Menendez indictment could see pharma lose a key ally

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Data show record exodus of life scientists from academia

Tuskegee Airman Raymond Cassagnol dies at 102

hotspot

hotspot

explore

How one medical school became remarkably diverse

UnitedHealth wins $3.3 billion takeover of Amedisys

Trump demands the U.S. pay no more for drugs than other countries … again

Cigna to pay $172 million to settle Medicare Advantage fraud probe

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Brazil's Jair Bolsonaro is barred from running for office until 2030

Hollywood unions extend contract negotiations for actors

Medical experts exlpore how to eliminate bias in clinical algorithms

Jerome Adams on the need for new antivirals for Covid

Listen: Who gets the credit for GLP

leisure time

The simple reason for the increase in autism diagnosis

The strange history of BMI, the body mass index

Listen: Who gets the credit for GLP

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Sudafed saga points to U.S. issues with evaluating older drugs

Here's how to stay safe from wildfire smoke amid reduced air quality

Wikipedia

focus

explore

hotspot